1. Introduction {#sec1-molecules-22-01558}
===============

The *Erythrina* genus, including approximately 200 species, is mainly distributed in tropical and subtropical areas. Four local and six introduced *Erythrina* species are distributed in China \[[@B1-molecules-22-01558]\]. *Erythrina crista-galli* L. (Fabaceae), known as cockspur coral tree, is a popular ornamental plant in South America and tropical and subtropical regions of South Asia. Pharmacological investigations have demonstrated that *E. crista-galli* seed extracts possess sedative, hypertensive, laxative, and diuretic activities \[[@B2-molecules-22-01558]\]. Phytochemical studies on this plant showed the presence of *Erythrina* \[[@B3-molecules-22-01558],[@B4-molecules-22-01558]\] and benzylisoquinoline alkaloids \[[@B5-molecules-22-01558],[@B6-molecules-22-01558]\]. The alkaloids of the *Erythrina* type, which possess a unique spirocyclic structure, are responsible for these activities. Great efforts have been made to reveal the biosynthetic pathway and mechanism for the *Erythrina* alkaloid biosynthesis in the past few decades \[[@B2-molecules-22-01558]\]. Furthermore, there are chemical studies on its non-alkaloidal constituents, in which flavonoids, cinnamylphenols and pterocarpans were reported functioning as phytoalexins and possessing antimicrobial activity \[[@B7-molecules-22-01558],[@B8-molecules-22-01558],[@B9-molecules-22-01558],[@B10-molecules-22-01558],[@B11-molecules-22-01558]\]. In this paper, we describe the isolation and structural characterization of a new *Erythrina* alkaloids glucoside, erythraline-11β-*[O]{.smallcaps}*-glucopyranoside (**1**), together with six known alkaloids (**2**--**7**) ([Figure 1](#molecules-22-01558-f001){ref-type="fig"}) from the seeds of *Erythrina crista-galli*, and these isolated compounds were evaluated for their inhibitory activity against tobacco mosaic virus (TMV) using the leaf-disc method.

2. Results and Discussion {#sec2-molecules-22-01558}
=========================

Phytochemical study of MeOH extract of the seeds of *Erythrina crista-galli* led to the isolation of a new Erythrinan alkaloid glucoside, erythraline-11β-*[O]{.smallcaps}*-glucopyranoside (**1**), together with five known Erythrinan alkaloids, erythraline (**2**) \[[@B12-molecules-22-01558]\], erythratine (**3**) \[[@B13-molecules-22-01558]\], erysodine (**4**) \[[@B14-molecules-22-01558]\], erysotrine (**5**) \[[@B13-molecules-22-01558]\], (+)-16β-[d]{.smallcaps}-glucoerysopine (**6**) \[[@B15-molecules-22-01558]\], and an indole alkaloid, (−)-hypaphorine (**7**) \[[@B16-molecules-22-01558]\] ([Figure 1](#molecules-22-01558-f001){ref-type="fig"}). The known structures were identified by comparison of their spectroscopic data with those reported in the literature.

Compound **1** was isolated as a white amorphous powder. It was assigned with a molecular formula of C~24~H~29~NO~9~ by HR-ESI-MS at *m*/*z* = 510.1537 \[M + Cl\]^−^ (Calcd for C~24~H~29~ClNO~9~, 510.1536). The IR spectrum ([Supplementary Materials](#app1-molecules-22-01558){ref-type="app"}) exhibited absorption bands due to an aromatic moiety and a conjugate olefin (1627, 1503, 1482 cm^−1^). The ^1^H-NMR and HSQC spectrum of **1** indicated the presence of a tetrasubstituted aromatic ring \[*δ*~H~ 6.73 (1H, s) and 7.15 (1H, s)\], a dioxy-methylene \[*δ*~H~ 5.91 (1H, d, *J* = 1.2 Hz), 5.90 (1H, d, *J* = 1.2 Hz)\], two olefins including a trisubstituted one \[*δ*~H~ 6.59 (1H, dd, *J* = 10.2, 2.1 Hz), 6.04 (1H, d, *J* = 10.2 Hz), 5.78 (1H, br s)\], three methylene groups \[*δ*~H~ 3.89 (1H, br d, *J* = 15.5 Hz), 3.70 (1H, dd, *J* = 15.5, 3.0 Hz), 3.57 (1H, dd, *J* = 14.1, 4.8 Hz), 3.37--3.30 (1H, overlap), 2.46 (1H, dd, *J* = 11.5, 5.5 Hz), 1.73 (1H, dd, *J* = 11.5, 10.4 Hz)\], a methoxy group \[*δ*~H~ 3.34 (3H, s)\], and a glucopyranosyl moiety \[*δ*~H~ 4.61 (1H, d, *J* = 7.8 Hz), 3.92 (1H, dd, *J* = 11.8, 2.0 Hz), 3.73 (1H, dd, *J* = 11.8, 5.4 Hz), 3.42 (1H, t, *J* = 8.7 Hz), 3.39--3.28 (2H, overlap), 3.23 (1H, dd, *J* = 9.2, 7.8 Hz)\]. Its ^13^C-NMR and DEPT spectra showed 24 carbon resonances, including one methoxy, five methylenes, twelve methines, and six quaternary carbons (including one olefinic). The ^13^C-NMR data of **1** were similar to those of erythraline (**2**), except for the additional signals for a glucopyranosyl group at *δ*~C~ 105.9 (C-1'), 78.2 (C-3'), 78.0 (C-5'), 75.4 (C-2'), 71.6 (C-4′), and 62.8 (C-6'), as well as an oxygenated methine appearing at *δ*~C~ 74.5 instead of a methylene carbon appearing at *δ*~C~ 25.3 (C-11) in that of **2**. The data above suggested a glucose moiety attached through an oxygen to C-11. The glucoside must have a β attachment, since the anomeric proton H-1′ (*δ*~H~ 4.61) exhibits a diaxial coupling (*J* = 7.8 Hz) with H-2' (*δ*~H~ 3.23). The HMBC and ^1^H-^1^H COSY correlations ([Figure 2](#molecules-22-01558-f002){ref-type="fig"}) confirmed that **1** was a typical Erythrinan alkaloid having a characteristic spiro-carbon positioned in the center of rings A, B, and C with two olefins of ∆ ^1,2^ and ∆ ^6,7^ and a dioxy-methylene group attached to the C-15 and C-16. The presence of a glucose moiety at C-11 was further confirmed by HMBC correlation observed from the anomeric proton H-1' to C-11. The HMBC correlation from methoxy protons H-18 (*δ*~H~ 3.32) to C-3 (*δ*~C~ 77.4) indicated that C-3 was substituted with a methoxy group. The relative configuration of **1** was determined by NOESY experiment. The observed cross-peaks ([Figure 3](#molecules-22-01558-f003){ref-type="fig"}) between H-3/H-14, H-4β, and correlations between H-4β/H-11, H-10α implied that the protons at C-3 and C-11 were placed at β- and α-orientation, respectively. Therefore, the structure of **1** was established as erythraline-11β-*[O]{.smallcaps}*-glucopyranoside. Biogenetic considerations on *Erythrina* alkaloids and the positive optical rotation value suggested that **1** has an *S* configuration at C-5 \[[@B6-molecules-22-01558],[@B14-molecules-22-01558],[@B17-molecules-22-01558]\].

Alkaloids **1**--**7** showed potent inhibition against the replication of TMV at a concentration of 500 μg/mL, with inhibitory rates varying from 52.1% to 79.7% ([Figure 4](#molecules-22-01558-f004){ref-type="fig"}). A commercial antiviral agent, ningnanmycin, exhibited 91.7% inhibition as tested under the same condition. Furthermore, the IC~50~ values of alkaloids **1**--**7** were determined as 0.59, 1.52, 1.04, 1.48, 1.28, 0.74, and 1.69 mM using the leaf-disc method, while the positive control, ningnanmycin, possessed an IC~50~ of 0.18 mM during a test under the same condition. The new alkaloid glycoside, erythraline-11β-*[O]{.smallcaps}*-glucopyranoside (**1**), showed a noticeable increase in the inhibition against TMV as compared with its aglycone, erythraline (**2**).

3. Materials and Methods {#sec3-molecules-22-01558}
========================

3.1. General Experimental Procedures {#sec3dot1-molecules-22-01558}
------------------------------------

Optical rotations were measured on a JASCO-1020 polarimeter (JASCO, Tokyo, Japan). UV spectra were measured using a Perkin Elmer Lambda 800 UV/VIS spectrometer (PerkinElmer, Waltham, MA, USA). IR spectra were obtained with a Thermo Nicolet Avatar 360 FT-IR spectrometer (Thermo Nicolet Corporation, Madison, WI, USA). ^1^H- and ^13^C-NMR spectra were obtained with a Bruker AVANCE III 500 spectrometer (Bruker BioSpin, Rheinstetten, Germany) using tetramethylsilane as an internal standard. HRESIMS were obtained with a Thermo Scientific™ TSQ Quantum Access MAX triple stage quadrupole mass spectrometer (Thermo Scientific, San Jose, CA, USA). Sephadex LH--20 (25--100 μm, Pharmacia Fine Chemical Co., Ltd., Uppsala, Sweden), Lichroprep RP-18 gel (40--63 μm, Merck, Darmstade, Germany), Silica gel (200--300 mesh) and Silica gel H (Qingdao Oceanic Chemical Co., Qingdao, China) were used for column chromatography. Thin-layer chromatography (TLC) was performed on glass-backed plates coated with 0.25 mm layers of Silica gel H (Qingdao Oceanic Chemical Co., Qingdao, China). Fractions were monitored by TLC and spots were visualized by heating silica gel plates sprayed with 5% H~2~SO~4~ in EtOH. All solvents and chemicals used were of analytical reagent grade (Sinopharm Chemical Reagent Co., Ltd., Beijing, China), and water was doubly distilled before use.

3.2. Plant Materials {#sec3dot2-molecules-22-01558}
--------------------

The seeds of *Erythrina crista-galli* L. were collected in July 2016 at the Fujian Agriculture and Forestry University (Fuzhou, China), and identified by Professor Chun-Mei Huang. Herbarium specimens were deposited at the Key Laboratory of Bio-Pesticide and Chemistry-Biology, Ministry of Education, Fujian Agriculture and Forestry University, Fuzhou, China (Specimen number: EC16701S).

3.3. Extraction and Isolation {#sec3dot3-molecules-22-01558}
-----------------------------

The seeds of *E. crista-galli* L. (dried and powdered, 950 g) was extracted with MeOH (2 L, 3 d) at room temperature three times. The MeOH extracts (150 g) were dissolved in H~2~O and successively partitioned between petroleum ether, EtOAc, and n-BuOH. The EtOAc-soluble materials (7.8 g) were subjected to silica gel (200--300 mesh) column chromatography and eluted with acetone in petroleum ether (from 100:0 to 0:100) to obtained 13 fractions (Fractions 1--13). Fraction 6 (145 mg) and Fraction 7 (2.5 g) were purified with RP--18 gel column chromatography, eluting with MeOH in H~2~O (80%), and then subjected to silica gel (H, eluted with CHCl~3~/MeOH, 99:1) column chromatography, respectively, to yield Compound **2** (11.5 mg) and Compound **5** (93.8 mg). Fraction 9 (205.0 mg) was first separated with an ODS column chromatography, eluting with MeOH in H~2~O (70%), and then subjected to silica gel (H, eluted with CHCl~3~/MeOH, 98:2) column chromatography, to yield Compound **4** (35.8 mg). Fraction 11 (250 mg) was purified with RP--18 gel column chromatography, eluting with MeOH in H~2~O (60%), and then subjected to silica gel (H, eluted with CHCl~3~/MeOH, 95:5) column chromatography, to yield Compound **3** (28.1 mg). Fraction 12 (1.05 g) was purified with ODS column chromatography, eluting with MeOH in H~2~O (60%), and then subjected to silica gel (H, eluted with CHCl~3~/MeOH, 90:10) column chromatography, to yield Compound **1** (17.1 mg) and Compound **6** (23.1 mg). Fraction 13 (424 mg) was purified with ODS column chromatography, eluting with MeOH in H~2~O (40%) to yield Compound **7** (39.2 mg).

*Erythraline-11β-[O]{.smallcaps}-glucopyranoside* (**1**). White amorphous powder. ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ + 130.6 (*c* 0.1 MeOH); UV (MeOH) λ~max~ (log ε): 205 (1.97), 226 (0.89), 287 (0.22); IR (KBr) υ~max~: 1627, 1503, 1482 cm^−1^; HR-ESI-MS *m*/*z*: 510.1537 (Calcd for C~24~H~29~ClNO~9~, 510.1536); ^1^H-NMR (500 MHz, CD~3~OD) and ^13^C-NMR (125 MHz, CD~3~OD) data (see [Table 1](#molecules-22-01558-t001){ref-type="table"}).

3.4. Anti-TMV Assay {#sec3dot4-molecules-22-01558}
-------------------

### 3.4.1. Virus and Host Plant {#sec3dot4dot1-molecules-22-01558}

Purified TMV (strain U1) was obtained from Institute of Plant Virology, Fujian Agriculture and Forestry University, Fuzhou, Fujian, China, whose concentration was determined as 15 mg/mL using an ultraviolet spectrophotometer method (${virus}\ {concentration}\  = \ (A_{260}\  \times \ {dilution}\ {ration})\ /{\ E}_{1\ {cm}}^{0.1\%,\ 260\ {nm}}$). The purified virus was kept at −20 °C and was diluted to 30 μg/mL with 0.01 M PBS before use. *Nicotiana tabacum* cv. K326, which were cultivated and grown to a 5--6-leaf stage in an insect-free greenhouse, were used as an anti-TMV assay, as a systemic TMV infection host. Purified compounds were dissolved in DMSO and diluted with 0.01 M PBS to a certain concentration for test. The final concentration of DMSO in the test solution (≤2%) showed no adverse effect on the plants.

### 3.4.2. Leaf-Disc Method {#sec3dot4dot2-molecules-22-01558}

Growing leaves of *N. tabacum* cv. K326 were mechanically inoculated with TMV (30 μg/mL in 0.01 M PBS). After 6 h, leaf discs (1 cm diameter) were punched and floated on solutions for test. Discs of healthy and inoculated leaves floated on a solution of 0.01 M PBS with 2% DMSO were used as a mock and negative control, respectively. Three replicates were carried out for each sample. After incubating for 48 h at 25 °C in a culture chamber, the leaf discs were grounded in 0.01 M carbonate coating buffer (pH 9.6), and OD~405~ values were measured using TAS-ELISA method. TAS-ELISA was performed as described in the literature \[[@B18-molecules-22-01558],[@B19-molecules-22-01558]\]. Virus concentration was calculated from a standard curve constructed using OD~405~ values of purified TMV at concentrations of 1.0, 0.5, 0.25, 0.125, and 0.0625 μg/mL. The inhibition of test solutions on TMV was calculated as follows: inhibition rate = \[1 − (virus concentration of treatment) / (virus concentration of negative control)\] × 100%.

4. Conclusions {#sec4-molecules-22-01558}
==============

A new *Erythrina* alkaloid glycoside together with five known *Erythrina* alkaloids and an indole alkaloid have been isolated from the MeOH extract of the seeds of *Erythrina Crista-galli* L. All the isolated alkaloids showed noticeable inhibition against the replication of TMV but in a relatively higher concentration as compared with that of the positive control agent. Further investigations are needed to reveal the biological action mechanism of *Erythrina* alkaloids.
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molecules-22-01558-t001_Table 1

###### 

^1^H- and ^13^C-NMR data of Compounds **1** and **2** (*δ* in ppm, CD~3~OD)

  ---------------------------------------------------------------------------------------------------------------------------------------
  Position   1       2                                                                               
  ---------- ------- ----------------------------------------------------------------------- ------- ------------------------------------
  C-1        126.2   6.59 (1H, dd, *J* = 10.2, 2.1 Hz)                                       125.4   6.53 (1H, dd, *J* = 10.1, 2.3 Hz)

  C-2        132.7   6.04 (1H, d, *J* = 10.2 Hz)                                             131.6   5.97 (1H, d, *J* = 10.1 Hz)

  C-3        77.4    4.01 (1H, m)                                                            76.2    3.96 (1H, m)

  C-4        41.2    2.46 (1H, dd, *J* = 11.5, 5.5 Hz), 1.73 (1H, dd, *J* = 11.5, 10.4 Hz)   42.0    2.49 (1H, dd, *J* = 11.5, 5.5 Hz)\
                                                                                                     1.83 (1H, dd, *J* = 11.5, 10.4 Hz)

  C-5        67.8    □                                                                       67.5    □

  C-6        143.7   □                                                                       142.4   □

  C-7        124.5   5.78 (1H, br s)                                                         123.1   5.72 (1H, br s, 1H)

  C-8        59.3    3.89 (1H, br d, *J* = 15.5 Hz)\                                         57.7    3.72 (1H, dd, *J* = 14.5, 3.0 Hz)\
                     3.70 (1H, dd, *J* = 15.5, 3.0 Hz)                                               3.53--3.45 (1H, overlap)

  C-10       50.4    3.57 (1H, dd, *J* = 14.1, 4.8 Hz)\                                      44.6    3.53--3.45 (1H, overlap)\
                     3.37--3.30 (1H, overlap)                                                        2.92--2.83 (1H, overlap)

  C-11       74.5    4.70 (1H, t, *J* = 4.3 Hz)                                              25.3    2.92--2.83 (1H, overlap)\
                                                                                                     2.71--2.64 (1H, m)

  C-12       129.1   □                                                                       128.1   □

  C-13       132.0   □                                                                       132.7   □

  C-14       106.3   6.73 (1H, s)                                                            106.3   6.62 (1H, s)

  C-15       148.9   □                                                                       146.2   □

  C-16       148.1   □                                                                       145.9   □

  C-17       109.7   7.15 (1H, s)                                                            108.8   6.76 (1H, s)

  C-18       56.6    3.34 (3H, s)                                                            56.1    3.32 (3H, s)

  C-19       102.3   5.91 (1H, d, *J* = 1.2 Hz)\                                             100.8   5.90 (1H, d, *J* = 1.5 Hz)\
                     5.90 (1H, d, *J* = 1.2 Hz)                                                      5.87 (1H, d, *J* = 1.5 Hz)

  C-1′       105.9   4.61 (1H, d, *J* = 7.8 Hz)                                              □       □

  C-2′       75.4    3.23 (1H, dd, *J* = 9.2, 7.8 Hz)                                        □       □

  C-3′       78.2    3.42 (1H, t, *J* = 8.8 Hz)                                              □       □

  C-4′       71.6    3.39--3.28 (1H, overlap)                                                □       □

  C-5′       78.0    3.39--3.28 (1H, overlap)                                                □       □

  C-6′       62.8    3.92 (1H, dd, *J* = 11.8, 2.0 Hz)\                                      □       □
                     3.73 (1H, dd, *J* = 11.8, 5.4 Hz)                                               
  ---------------------------------------------------------------------------------------------------------------------------------------
